United Therapeutics Stock Predictions

Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

Buy

UTHR
United Therapeutics

Last Price:

$307.77

Seasonality Move:

10.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Disrupting a Trillion-Dollar Industry

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

United Therapeutics Stock Forecast

Over the next 52 weeks, United Therapeutics has on average historically risen by 19.1% based on the past 25 years of stock performance.
United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%
Is United Therapeutics Stock Undervalued?

The current United Therapeutics [UTHR] share price is $308.72. The Score for UTHR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
UTHR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will United Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, United Therapeutics has on average historically risen by 19.1% based on the past 25 years of stock performance.

United Therapeutics Stock Rating

Buy

United Therapeutics (UTHR) is a Buy

Is United Therapeutics overpriced?

United Therapeutics has risen higher in 16 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 64%

United Therapeutics Stock Price History

Is UTHR stock going to rise?

The current trend is moderately bullish and UTHR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

unither.com

52-Week Data

52-Week High:

417.82

52-Week Low:

264.33

Prediction Charts

Market Cap:

13.9B

Price in USD:

308.72

Volume:

326K

Beta:

0.53

Technical Analysis

SMA50:

301.34

SMA100:

326.81

SMA200:

342.37

52-Wk Change:

11.68%

Stock Predictions

Is United Therapeutics stock public?

Yes, United Therapeutics is a publicly traded company.
What is the United Therapeutics stock quote today?

The United Therapeutics stock price is 308.72 USD today.
How to buy United Therapeutics stock online?

You can buy United Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
May-5	294.52	298.70	299.45	292.02
May-6	295.71	295.02	298.48	290.02
May-7	299.46	306.92	309.25	295.30
May-8	304.00	308.00	311.22	299.37
May-9	308.26	301.42	313.35	301.23
May-12	304.25	310.80	312.49	303.95
May-13	308.37	308.07	310.09	301.97
May-14	307.10	299.68	307.62	298.69
May-15	301.26	303.92	303.94	292.61
May-16	303.03	305.35	305.74	300.46
May-19	304.68	305.31	306.13	300.51
May-20	305.87	309.57	311.99	304.24
May-21	306.91	309.68	310.97	305.44
May-22	308.25	308.72	310.74	306.16

United Therapeutics Earnings

United Therapeutics Earnings Report: Per Share United Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

United Therapeutics Forecast Revenue Growth

United Therapeutics Stock Analysis: Historical quarterly revenues per share for United Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.80 per share, an increase next quarter of $0.13 per share, an increase this year of $2.51 per share, and an increase next year of $1.11 per share.

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.